0001104659-14-057230.txt : 20140806 0001104659-14-057230.hdr.sgml : 20140806 20140806090347 ACCESSION NUMBER: 0001104659-14-057230 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140805 FILED AS OF DATE: 20140806 DATE AS OF CHANGE: 20140806 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MARINUS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001267813 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 142 TEMPLE STREET, SUITE 205 CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-315-0566 MAIL ADDRESS: STREET 1: 142 TEMPLE STREET, SUITE 205 CITY: NEW HAVEN STATE: CT ZIP: 06510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Canaan Partners VII LLC CENTRAL INDEX KEY: 0001514133 STATE OF INCORPORATION: CT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36576 FILM NUMBER: 141018225 BUSINESS ADDRESS: STREET 1: 285 RIVERSIDE AVENUE STREET 2: STE. 250 CITY: WESTPORT STATE: CT ZIP: 06880 BUSINESS PHONE: 2038550400 MAIL ADDRESS: STREET 1: 285 RIVERSIDE AVENUE STREET 2: STE. 250 CITY: WESTPORT STATE: CT ZIP: 06880 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Canaan VII L P CENTRAL INDEX KEY: 0001327625 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36576 FILM NUMBER: 141018226 BUSINESS ADDRESS: STREET 1: C/O CANAAN MANAGEMENT INC STREET 2: 105 ROWAYTON AVE CITY: ROWAYTON STATE: CT ZIP: 06853 BUSINESS PHONE: 2038550400 MAIL ADDRESS: STREET 1: C/O CANAAN MANAGEMENT INC STREET 2: 105 ROWAYTON AVE CITY: ROWAYTON STATE: CT ZIP: 06853 4 1 a4.xml 4 X0306 4 2014-08-05 0 0001267813 MARINUS PHARMACEUTICALS INC MRNS 0001327625 Canaan VII L P 285 RIVERSIDE AVENUE SUITE 250 WESTPORT CT 06880 1 0 1 0 0001514133 Canaan Partners VII LLC 285 RIVERSIDE AVENUE SUITE 250 WESTPORT CT 06880 1 0 1 0 Common Stock 2014-08-05 4 C 0 1836398 A 1836398 I See Footnote Common Stock 2014-08-05 4 P 0 625000 8.00 A 2461398 I See Footnote Series A Preferred Stock 2014-08-05 4 C 0 4742516 D Common Stock 729618 0 I See Footnote Series B Preferred Stock 2014-08-05 4 C 0 3838214 D Common Stock 590494 0 I See Footnote Series C Preferred Stock 2014-08-05 4 C 0 3355859 D Common Stock 516286 0 I See Footnote Warrants to Purchase Series B Preferred Stock 2014-08-05 4 J 0 959553 10.86 D Common Stock 147624 0 I See Footnote Upon the closing of Issuer's initial public offering on August 5, 2014, the preferred stock, which has no expiration date and convertible at any time at the option of the holder, automatically converted, at a conversion ratio of one share of Common Stock for every 6.5 shares of preferred stock, for no additional consideration. Shares held directly by Canaan VII L.P. (the "Canaan Fund"). Canaan Partners VII LLC ("Canaan VII" and together with the Canaan Fund, the "Canaan Entities") is the sole general partner of the Canaan Fund and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Canaan VII disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of any pecuniary interest therein. Stephen Bloch, a manager of Canaan VII, serves as the representative of the Canaan Entities on the Issuer's board of directors. This warrant was immediately exercisable. Upon the closing of Issuer's public offering, the warrant was cancelled automatically and for no value in accordance with its terms as it was out-of-the-money.. Canaan VII L.P. By: Canaan Partners VII LLC its General Partner /s/ Jaime Slocum Attorney-in-Fact 2014-08-05 Canaan Partners VII LLC By: /s/ Jaime Slocum Attorney-in-Fact 2014-08-05